PAPER Beattie Z, Miller LM, Almirola C, Au-Yeung WM, Bernard H, Cosgrove KE, Dodge HH, Gamboa CJ, Golonka O, Gothard S, Harbison S, Irish S, Kornfeld J, Lee J, Marcoe J, Mattek NC, Quinn C, Reynolds C, Riley T, Rodrigues N, Sharma N, Siqueland MA, Thomas NW, Truty T, Wall R, Wild K, Wu CY, Karlawish J, Silverberg NB, Barnes LL, Czaja S, Silbert LC, Kaye J
SEARCH RESULTS
448 RESULTS
PAPER Liguori C, Spanetta M, Romoli M, Placidi F, Nardi Cesarini E, Mercuri NB, Costa C
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy.
Mech Ageing Dev. 2021 Mar;194:111434. Epub 2021 Jan 11 PubMed: 33444630PAPER Choudhury P, Ramanan VK, Boeve BF
APOE ɛ4 Allele Testing and Risk of Alzheimer Disease.
JAMA. 2021 Feb 2;325(5):484-485. PubMed: 33443531PAPER Sajjadi SA, Ash S, Cappa S
Preservation of Memory in Alzheimer-Related Primary Progressive Aphasia: Glass Half Full.
Neurology. 2021 Feb 9;96(6):243-244. Epub 2021 Jan 13 PubMed: 33441460PAPER Hamilton K, Harvey J
The Neuronal Actions of Leptin and the Implications for Treating Alzheimer's Disease.
Pharmaceuticals (Basel). 2021 Jan 11;14(1) PubMed: 33440796PAPER Petretto DR, Carrogu GP, Gaviano L, Pili L, Pili R
Dementia and Major Neurocognitive Disorders: Some Lessons Learned One Century after the first Alois Alzheimer's Clinical Notes.
Geriatrics (Basel). 2021 Jan 11;6(1) PubMed: 33440669PAPER Bell SM, Barnes K, De Marco M, Shaw PJ, Ferraiuolo L, Blackburn DJ, Venneri A, Mortiboys H
Mitochondrial Dysfunction in Alzheimer's Disease: A Biomarker of the Future?
Biomedicines. 2021 Jan 11;9(1) PubMed: 33440662PAPER Liang Z, Chan HY, Lee MM, Chan MK
A SUMO1-Derived Peptide Targeting SUMO-Interacting Motif Inhibits α-Synuclein Aggregation.
Cell Chem Biol. 2021 Feb 18;28(2):180-190.e6. Epub 2021 Jan 13 PubMed: 33444530PAPER Therriault J, Pascoal TA, Benedet AL, Tissot C, Savard M, Chamoun M, Lussier F, Kang MS, Berzgin G, Wang T, Fernandes-Arias J, Massarweh G, Soucy JP, Vitali P, Saha-Chaudhuri P, Gauthier S, Rosa-Neto P
Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE ε4, and Cognitive Impairment.
Neurology. 2021 Feb 16;96(7):e975-e985. Epub 2020 Dec 21 PubMed: 33443136PAPER Mesulam MM, Coventry C, Kuang A, Bigio EH, Mao Q, Flanagan ME, Gefen T, Sridhar J, Geula C, Zhang H, Weintraub S, Rogalski EJ
Memory Resilience in Alzheimer Disease With Primary Progressive Aphasia.
Neurology. 2021 Feb 9;96(6):e916-e925. Epub 2021 Jan 13 PubMed: 33441454PAPER Zhou Y, Fang J, Bekris LM, Kim YH, Pieper AA, Leverenz JB, Cummings J, Cheng F
AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
Alzheimers Res Ther. 2021 Jan 13;13(1):24. PubMed: 33441136PAPER Stutzmann GE
RyR2 calcium channels in the spotlight-I'm ready for my close up, Dr. Alzheimer!
Cell Calcium. 2021 Mar;94:102342. Epub 2021 Jan 2 PubMed: 33444912PAPER Govindarajulu M, Ramesh S, Neel L, Fabbrini M, Buabeid M, Fujihashi A, Dwyer D, Lynd T, Shah K, Mohanakumar KP, Smith F, Moore T, Dhanasekaran M
Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease.
Neurochem Int. 2021 Mar;144:104958. Epub 2021 Jan 12 PubMed: 33444675PAPER Tomoto T, Sugawara J, Tarumi T, Chiles C, Curtis B, Pasha EP, Cullum CM, Zhang R
Carotid Arterial Stiffness and Cerebral Blood Flow in Amnestic Mild Cognitive Impairment.
Curr Alzheimer Res. 2020;17(12):1115-1125. PubMed: 334410642022 Neurobiology of Brain Disorders Award
GRANT Friday, January 15, 2021- 15:30 The McKnight Endowment Fund for Neuroscience Up to four awards are made annually, each providing $100,000 per year for three years. LOIs are due on March 15, 2021 (midnight in the last time zone on earth). Full proposals ...
Current Filters
- Date Range : Jan 2021 to Jan 2021 x